Status:
RECRUITING
Analysis of Circulating Tumor Markers in Blood
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Conditions:
Cancer
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The circulating tumoral biomarkers in the blood are the object of numerous researches for several decades. The potential clinical interests of these circulating biomarkers are diagnostic, prognostic, ...
Detailed Description
The new major challenge in the research concerns the circulating biomarkers, which aim at replacing the molecular analyses on tumour tissue obtained by biopsy (for example the search for somatic mutat...
Eligibility Criteria
Inclusion
- Patient presenting an invasive tumoral pathology (proved or suspected), whatever is the location or the stage,
- Man or woman ≥ 18 years,
- Obtaining of the informed consent signed before any procedure of specific preselection on approval.
Exclusion
- Private persons of freedom or under guardianship,
- Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons,
- Pregnant woman and/or breast-feeding,
- Unaffiliated patient to Social Protection System,
Key Trial Info
Start Date :
May 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 29 2029
Estimated Enrollment :
992 Patients enrolled
Trial Details
Trial ID
NCT04025541
Start Date
May 29 2018
End Date
May 29 2029
Last Update
April 2 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Montpellier, France, 34298
2
ICM
Montpellier, France, 34298